PARP1 promotes EGFR-TKI drug-resistance via PI3K/AKT pathway in non-small-cell lung cancer
Article in Cancer Chemotherapy and Pharmacology (April 2024)
The most recent citing publications are shown below. View all 17 publications that cite this research output on Dimensions.
Article in Cancer Chemotherapy and Pharmacology (April 2024)
Preprint in bioRxiv (April 2024)
Article in British Journal of Cancer (March 2024)